The present invention encompasses compounds of the formula (I) wherein the groups A, Cy, XI and Y are defined herem, which are suitable for the treatment of a disease chosen from rheumatoid arthritis, systemic lupus erythromatosis, scleroderma, asthma, allergie rhinitis, allergie eczema, B cell lymphoma, multiple sclerosis, juvenile rheumatoid artlmtis, juvenile idiopathie arthritis, inflammatory bowd discase, grnil versus host disease, psoriatic arthritis, ankylosing spondylitis and uveitis.
